1.07
price down icon1.83%   -0.02
pre-market  Pre-market:  1.07  
loading
Canopy Growth Corporation stock is traded at $1.07, with a volume of 13.61M. It is down -1.83% in the last 24 hours and down -13.01% over the past month. Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
See More
Previous Close:
$1.09
Open:
$1.1
24h Volume:
13.61M
Relative Volume:
0.48
Market Cap:
$404.31M
Revenue:
$199.32M
Net Income/Loss:
$-272.74M
P/E Ratio:
-0.5489
EPS:
-1.9494
Net Cash Flow:
$-63.86M
1W Performance:
-7.76%
1M Performance:
-13.01%
6M Performance:
-32.28%
1Y Performance:
-40.88%
1-Day Range:
Value
$1.05
$1.11
1-Week Range:
Value
$1.05
$1.1587
52-Week Range:
Value
$0.77
$2.38

Canopy Growth Corporation Stock (CGC) Company Profile

Name
Name
Canopy Growth Corporation
Name
Phone
855-558-9333
Name
Address
1 Hershey Drive, Smiths Falls, ON
Name
Employee
2,000
Name
Twitter
@CanopyGrowth
Name
Next Earnings Date
2025-08-08
Name
Latest SEC Filings
Name
CGC's Discussions on Twitter

Compare CGC vs TAK, ZTS, HLN, TEVA, UTHR

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
CGC
Canopy Growth Corporation
1.07 411.87M 199.32M -272.74M -63.86M -1.9494
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
18.28 57.18B 29.85B 776.90M 4.35B 0.2408
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
128.67 56.47B 9.40B 2.65B 2.24B 5.935
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
11.16 49.16B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
34.31 40.03B 17.41B 1.43B 1.00B 1.2182
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
475.85 20.37B 3.13B 1.27B 1.12B 26.39

Canopy Growth Corporation Stock (CGC) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-10-25 Upgrade The Benchmark Company Sell → Hold
Apr-04-23 Upgrade Bernstein Underperform → Mkt Perform
Nov-02-22 Initiated Bernstein Underperform
Oct-26-22 Upgrade Canaccord Genuity Sell → Hold
Jun-08-22 Downgrade BMO Capital Markets Market Perform → Underperform
Mar-22-22 Downgrade Barclays Equal Weight → Underweight
Dec-22-21 Downgrade BofA Securities Neutral → Underperform
Dec-20-21 Downgrade Piper Sandler Neutral → Underweight
Dec-07-21 Initiated Wells Fargo Underweight
Nov-18-21 Initiated Barclays Equal Weight
Nov-08-21 Downgrade CIBC Neutral → Sector Underperform
Nov-08-21 Downgrade Canaccord Genuity Hold → Sell
Nov-08-21 Downgrade Cowen Outperform → Market Perform
Oct-01-21 Downgrade BofA Securities Buy → Neutral
Aug-12-21 Upgrade Jefferies Underperform → Hold
Jun-02-21 Upgrade Canaccord Genuity Sell → Hold
May-25-21 Upgrade MKM Partners Neutral → Buy
Apr-28-21 Resumed BofA Securities Buy
Feb-24-21 Downgrade Jefferies Hold → Underperform
Feb-10-21 Downgrade Canaccord Genuity Hold → Sell
Feb-10-21 Downgrade The Benchmark Company Buy → Hold
Feb-05-21 Downgrade Piper Sandler Overweight → Neutral
Sep-04-20 Upgrade CFRA Buy → Strong Buy
Jun-01-20 Downgrade BMO Capital Markets Outperform → Market Perform
Jun-01-20 Downgrade Bryan Garnier Neutral → Sell
Jun-01-20 Downgrade CIBC Sector Outperform → Neutral
Jun-01-20 Downgrade Ladenburg Thalmann Buy → Neutral
Jun-01-20 Downgrade Stifel Buy → Sell
May-22-20 Resumed BofA/Merrill Buy
Apr-16-20 Upgrade Jefferies Underperform → Hold
Jan-28-20 Upgrade BMO Capital Markets Market Perform → Outperform
Dec-12-19 Reiterated Cantor Fitzgerald Neutral
Nov-20-19 Upgrade BofA/Merrill Neutral → Buy
Nov-15-19 Downgrade Alliance Global Partners Buy → Neutral
Nov-05-19 Initiated Cantor Fitzgerald Neutral
Oct-14-19 Downgrade Seaport Global Securities Buy → Neutral
Oct-11-19 Downgrade Jefferies Hold → Underperform
Sep-27-19 Downgrade BofA/Merrill Buy → Neutral
Sep-20-19 Initiated MKM Partners Neutral
Sep-18-19 Initiated Oppenheimer Perform
Aug-26-19 Upgrade Seaport Global Securities Neutral → Buy
Jul-17-19 Initiated Ladenburg Thalmann Buy
View All

Canopy Growth Corporation Stock (CGC) Latest News

pulisher
12:38 PM

Should Canopy Growth stock be in your portfolio post Q3 earnings? - MSN

12:38 PM
pulisher
Feb 11, 2026

Should Canopy Growth Stock Be in Your Portfolio Post Q3 Earnings? - The Globe and Mail

Feb 11, 2026
pulisher
Feb 11, 2026

Promising Cannabis Stocks To ConsiderFebruary 11th - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Feb 11, 2026
pulisher
Feb 11, 2026

Canopy Growth Corporation Postpones Annual General and Special Shareholders Meeting Due to Insufficient Quorum - Intellectia AI

Feb 11, 2026
pulisher
Feb 10, 2026

Promising Cannabis Stocks To Watch TodayFebruary 10th - MarketBeat

Feb 10, 2026
pulisher
Feb 10, 2026

MTL Cannabis Reminds MTL Shareholders to Vote FOR the Arrangement Resolution to Approve the Proposed Plan of Arrangement with Canopy Growth at the Upcoming Special Meeting of MTL Shareholders - Newswire Canada

Feb 10, 2026
pulisher
Feb 10, 2026

Canopy Growth Reports Substantial Loss Reduction in Q3 Earnings - AD HOC NEWS

Feb 10, 2026
pulisher
Feb 10, 2026

(WEED) Proactive Strategies (WEED:CA) - Stock Traders Daily

Feb 10, 2026
pulisher
Feb 09, 2026

Canopy Growth Reports Mixed Quarterly Results and Strategic Acquisition - AD HOC NEWS

Feb 09, 2026
pulisher
Feb 09, 2026

Best Cannabis Stocks To ResearchFebruary 9th - MarketBeat

Feb 09, 2026
pulisher
Feb 09, 2026

Canopy Growth’s Mixed Quarter: Losses Narrow but Earnings Miss - AD HOC NEWS

Feb 09, 2026
pulisher
Feb 09, 2026

Canopy Growth Reports Sharply Narrowed Losses in Q3 - AD HOC NEWS

Feb 09, 2026
pulisher
Feb 08, 2026

Cannabis Stocks To Keep An Eye OnFebruary 8th - MarketBeat

Feb 08, 2026
pulisher
Feb 07, 2026

Canopy Growth’s Narrowing Losses Met With Analyst Skepticism - AD HOC NEWS

Feb 07, 2026
pulisher
Feb 07, 2026

Canopy Growth (TSX:WEED) Valuation Check After Narrowed Losses And New Shelf Registration - Yahoo Finance

Feb 07, 2026
pulisher
Feb 07, 2026

Cannabis Stocks To ResearchFebruary 7th - MarketBeat

Feb 07, 2026
pulisher
Feb 07, 2026

Canopy Growth signals positive adjusted EBITDA in fiscal 2027 amid MTL acquisition and expanding European focus - MSN

Feb 07, 2026
pulisher
Feb 07, 2026

Is It Time to Dump Your Shares of Canopy Growth Corp? - Yahoo Finance

Feb 07, 2026
pulisher
Feb 07, 2026

Canopy Growth Corporation (NASDAQ:CGC) Q3 2026 Earnings Call Transcript - Insider Monkey

Feb 07, 2026
pulisher
Feb 07, 2026

When (WEED) Moves Investors should Listen (WEED:CA) - Stock Traders Daily

Feb 07, 2026
pulisher
Feb 07, 2026

Wall Street Zen Downgrades Canopy Growth (NASDAQ:CGC) to Sell - MarketBeat

Feb 07, 2026
pulisher
Feb 06, 2026

Canopy Growth Narrows Losses Amid Strategic Restructuring - AD HOC NEWS

Feb 06, 2026
pulisher
Feb 06, 2026

Canopy Growth Q3 2026 Earnings Call Transcript - MarketBeat

Feb 06, 2026
pulisher
Feb 06, 2026

Canopy Growth (CGC) Announces Sale of 18.71 Million Common Shares - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

Canopy Growth Q3 Earnings Call Highlights - MarketBeat

Feb 06, 2026
pulisher
Feb 06, 2026

Cannabis Stocks To Watch TodayFebruary 6th - MarketBeat

Feb 06, 2026
pulisher
Feb 06, 2026

Canopy Growth Corp (CGC) Q3 2026 Earnings Call Highlights: Navigating Growth and Challenges in ... By GuruFocus - Investing.com Canada

Feb 06, 2026
pulisher
Feb 06, 2026

Canopy Growth (NASDAQ:CGC) Posts Earnings Results, Misses Estimates By $0.07 EPS - MarketBeat

Feb 06, 2026
pulisher
Feb 06, 2026

Canopy Growth Corp (TSX:WEED) Shifts Focus While Tracking TSX Smallcap Index Today - Kalkine Media

Feb 06, 2026
pulisher
Feb 06, 2026

Canopy’s domestic sales increase in Q3 2026 while international sales decline - StratCann

Feb 06, 2026
pulisher
Feb 06, 2026

Earnings call transcript: Canopy Growth Q3 2026 misses EPS, beats revenue - Investing.com

Feb 06, 2026
pulisher
Feb 06, 2026

WEED: Revenue growth, cost savings, and MTL acquisition position for positive EBITDA in 2027 - TradingView

Feb 06, 2026
pulisher
Feb 06, 2026

WEED: Q3 delivered revenue growth, improved margins, and a stronger balance sheet, with MTL acquisition ahead - TradingView

Feb 06, 2026
pulisher
Feb 06, 2026

Canopy Growth Reports Narrowed Losses Amid Strategic Overhaul - AD HOC NEWS

Feb 06, 2026
pulisher
Feb 06, 2026

Stocks in play: Canopy Growth Corporation - Barchart.com

Feb 06, 2026
pulisher
Feb 06, 2026

Should You Buy, Hold or Sell ACB Stock Post Q3 Earnings Release? - The Globe and Mail

Feb 06, 2026
pulisher
Feb 06, 2026

Canopy Growth posts mixed Q3 results, narrower loss amid ongoing cost cuts - Proactive financial news

Feb 06, 2026
pulisher
Feb 06, 2026

Canopy Growth reports Q3 EPS (C$0.18) vs. (C$1.11) last year - TipRanks

Feb 06, 2026
pulisher
Feb 06, 2026

Canopy Growth (CGC) Q3 FY2026 earnings: loss narrows by 49% - grafa.com

Feb 06, 2026
pulisher
Feb 06, 2026

Canopy Growth Corporation (CGC) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Feb 06, 2026
pulisher
Feb 06, 2026

Canopy Growth Narrows Losses and Bolsters Balance Sheet as Canadian Cannabis Sales Rise - TipRanks

Feb 06, 2026
pulisher
Feb 06, 2026

Canopy Growth Q3 Net Loss Narrows - marketscreener.com

Feb 06, 2026
pulisher
Feb 06, 2026

Canopy Growth posts Q3 FY26 results (CGC:NASDAQ) - Seeking Alpha

Feb 06, 2026
pulisher
Feb 06, 2026

Canopy Growth Brief: Citing $371M in Cash and Cash Equivalents With a Net Cash Position of $146M at Dec. 31, 2025 - marketscreener.com

Feb 06, 2026
pulisher
Feb 06, 2026

Canopy Growth Brief: Basic and Diluted Loss Per Share $0.18 - marketscreener.com

Feb 06, 2026
pulisher
Feb 06, 2026

Canopy Growth Reports Third Quarter Fiscal 2026 Financial Results - The Globe and Mail

Feb 06, 2026
pulisher
Feb 06, 2026

WEED: Net loss narrowed 49% year-over-year as Canadian cannabis revenue grew and cost savings took hold - TradingView

Feb 06, 2026
pulisher
Feb 06, 2026

Canopy Growth Q3 revenue beats estimates driven by insured patients, larger orders - TradingView

Feb 06, 2026
pulisher
Feb 06, 2026

Canopy Growth (CGC) Misses Q3 EPS by 14c - StreetInsider

Feb 06, 2026
pulisher
Feb 06, 2026

Canopy Growth Corp SEC 10-Q Report - TradingView

Feb 06, 2026

Canopy Growth Corporation Stock (CGC) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
drug_manufacturers_specialty_generic RDY
$14.21
price up icon 1.21%
$25.71
price up icon 0.39%
drug_manufacturers_specialty_generic RGC
$26.72
price up icon 0.15%
$137.44
price down icon 0.15%
$16.13
price up icon 1.13%
$475.85
price up icon 0.56%
Cap:     |  Volume (24h):